We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$111M
AUM Growth
-$126M
Cap. Flow
-$134M
Cap. Flow %
-120.72%
Top 10 Hldgs %
78.01%
Holding
398
New
12
Increased
24
Reduced
76
Closed
225

Sector Composition

Rank Sector Weight
1 Financials 49.19%
2 Healthcare 6.04%
3 Industrials 4.76%
4 Technology 3.89%
5 Communication Services 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHT
101
DELISTED
Red Hat Inc
RHT
$22K 0.02%
200
GSK icon
102
GSK
GSK
$107B
$20K 0.02%
392
-80
-17% -$4.06K
KO icon
103
Coca-Cola
KO
$383B
$20K 0.02%
435
-936
-68% -$42.6K
NPKI
104
NPK International
NPKI
$1.02B
$20K 0.02%
2,000
AVGO icon
105
Broadcom
AVGO
$1.76T
$19K 0.02%
800
VZ icon
106
Verizon
VZ
$197B
$19K 0.02%
391
-3,159
-89% -$149K
DJP icon
107
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$801M
$18K 0.02%
757
-44
-5% -$1.01K
NKE icon
108
Nike
NKE
$64.1B
$18K 0.02%
350
SGEN
109
DELISTED
Seagen Inc. Common Stock
SGEN
$18K 0.02%
330
WSM icon
110
Williams-Sonoma
WSM
$27.5B
$17K 0.02%
+700
New +$16.3K
T icon
111
AT&T
T
$164B
$16K 0.01%
547
-8,054
-94% -$229K
CERN
112
DELISTED
Cerner Corp
CERN
$16K 0.01%
230
-799
-78% -$53K
EFA icon
113
iShares MSCI EAFE ETF
EFA
$76.4B
$15K 0.01%
230
-12,310
-98% -$823K
NBIX icon
114
Neurocrine Biosciences
NBIX
$18.2B
$15K 0.01%
+250
New +$13.2K
VV icon
115
Vanguard Morningstar Large-Cap ETF
VV
$51.2B
$15K 0.01%
133
+1
+0.8% +$113
CAT icon
116
Caterpillar
CAT
$361B
$14K 0.01%
110
IQV icon
117
IQVIA
IQV
$40.7B
$14K 0.01%
150
NEE icon
118
NextEra Energy
NEE
$185B
$14K 0.01%
380
-64
-14% -$2.34K
PSX icon
119
Phillips 66
PSX
$82.9B
$14K 0.01%
154
REXX
120
DELISTED
Rex Energy Corporation
REXX
$14K 0.01%
5,000
BAC icon
121
Bank of America
BAC
$429B
$13K 0.01%
500
GILD icon
122
Gilead Sciences
GILD
$165B
$13K 0.01%
161
-5,500
-97% -$421K
SPYG icon
123
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$49.4B
$13K 0.01%
416
+4
+1% +$122
NAGE
124
Niagen Bioscience
NAGE
$256M
$13K 0.01%
3,000
RTN
125
DELISTED
Raytheon Company
RTN
$13K 0.01%
71
-2,749
-97% -$484K

Similar funds

Pathstone Family Office's Q3 2017 Portfolio in Review

As of Q3 2017, Pathstone Family Office held 398 positions worth $111M, down 53% from $237M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Pathstone Family Office withdrew a net $134M in Q3 2017, closing 225 positions and reducing 76 holdings. Its most notable exit was Everforth Inc, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pathstone Family Office opened a new position in Vanguard Russell 1000 ETF worth $332K.

  • Pathstone Family Office's largest Q3 2017 buy was Vanguard Russell 1000 ETF: 2,875 shares worth $332K.
  • Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $124K increase.
  • Pathstone Family Office's biggest Q3 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $31.2M.
  • Pathstone Family Office fully exited Everforth Inc in Q3 2017, selling an estimated $16.4M.
  • Pathstone Family Office's ten largest holdings make up 78% of its $111M portfolio in Q3 2017.
  • Pathstone Family Office opened 12 new positions and closed 225 in Q3 2017.
  • Pathstone Family Office's portfolio value fell 53% quarter-over-quarter to $111M.

Based on Pathstone Family Office's 13F filing for Q3 2017, filed 14 Nov 2017.